Southern Industrial Constructors (SIC) served as a major Tier II partner for this project, which was the Southeast region’s largest-ever pharmaceutical/biotherapeutics investment. SIC partnered with the client’s program manager to self-perform services and successfully deliver the project.
We were responsible for nearly 70 percent of the process and utility equipment installation. Utilizing a local business unit to provide project management, support, and craft labor, our team provided as many as 20 crew members at a time. This strategy reduced long-term mobilization and subsistence costs.
Additionally, our creative contract model provided cost savings on engineering completion.
The client sought to build a facility to produce oral insulin to meet the North American market’s increasing demand for domestic insulin production.
For years, the client had relied upon overseas manufacturing and North Carolina-based fill and finish capabilities to supply the U.S. market. Domestic manufacturing would help reduce the costs of international production.
SIC provided equipment rigging, millwrighting, supplemental steel, and commissioning services. Our scope of work included:
- Mobile crane services for fixed-price vessel installation (these were the project’s largest equipment components)
- Process equipment offloading and staging
- Rigging and millwrighting fermentation, purification, and recovery equipment
- Fabricating, erecting, and installing miscellaneous support and supplemental steel for equipment support and stability
- Commissioning and plant start-up
The client is a leading multinational pharmaceutical company and a primary market owner of global insulin production.